CTLA4 and posterior cortical atrophy: In our study, we developed an integrin αvβ3/α6β1-based risk model that can accurately predict immune cell infiltration, immune cell function, immune exclusion score and immune checkpoint levels (PD-1, PD-L1 and CTLA-4) in PCa patients.